Neuroplast successfully completes patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury

16 patients have been enrolled in a multicenter international, randomized, placebo-controlled, double-blinded Phase II clinical trial Goal: to determine the effect size of Neuro-Cells®, a stem-cell treatment for Traumatic Spinal Cord Injury (TSCI) Confirmed excellent safety and…